NEW · Pharmaceuticals
BMY
Bristol-Myers Squibb Co · $124.91B
61.15
-0.50%
Price
251 sessions shownTechnicals
from daily closesRSI · 14 day
33.3
Avg true range · 14d
2.18%
Volatility · 20d annualised
19.8%
Trend · 20d vs 50d
Down
vs 20-day average
-3.15%
vs 50-day average
-5.20%
vs 200-day average
2.95%
200-day average
59.40
Internals
where it sits, and how hard it is being traded52-week low
42.52
52-week high
68.64
Volume vs its 20-day avg
0.84×
Beta vs the market
0.19
Sitting 71% of the way up its 52-week range (42.52 → 68.64)
Swings
prices it actually turned at — highest or lowest of the surrounding 11 sessionsTurned down · Aug 3
68.10
Turned down · Aug 19
68.64
Turned down · Sep 3
68.24
Turned up · Jul 14
56.78
Turned up · Aug 12
63.00
Turned up · Sep 24
60.60
Fundamentals
P/E
13.46
Fwd P/E
—
P/S
2.54
P/B
5.94
EV/EBITDA
10.57
ROE
46.8%
ROA
10.3%
Gross margin
71.7%
Net margin
—
Debt / equity
2.44
Rev growth
3.1%
EPS growth
5.5%
Earnings
Next report
Oct 29, 2026
EPS expected
1.74
News
stories naming this company, last 21 daysEvery figure here is measured from live market data as of Oct 4, 05:02 PM. Nothing is estimated or filled in — where a figure shows — the source had no value for it, and a section you don’t see had no data at all. This describes what the market has already done. It is not a forecast, and not financial advice.